727 related articles for article (PubMed ID: 25601619)
1. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Malhi S; Gu X
Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
3. Approaches for targeting cancer stem cells drug resistance.
Rosa R; D'Amato V; De Placido S; Bianco R
Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
[TBL] [Abstract][Full Text] [Related]
4. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
5. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell-targeted therapeutics and delivery strategies.
Ahmad G; Amiji MM
Expert Opin Drug Deliv; 2017 Aug; 14(8):997-1008. PubMed ID: 27866420
[TBL] [Abstract][Full Text] [Related]
7. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
8. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
Krishnamurthy S; Ke X; Yang YY
Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
10. Existing drugs and their application in drug discovery targeting cancer stem cells.
Lv J; Shim JS
Arch Pharm Res; 2015 Sep; 38(9):1617-26. PubMed ID: 26152874
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
Zhang Z; Deng Q; Xiao C; Li Z; Yang X
Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
[TBL] [Abstract][Full Text] [Related]
12. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
Li L; Ni R; Zheng D; Chen L
Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
[TBL] [Abstract][Full Text] [Related]
13. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
Singh VK; Saini A; Chandra R
Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
[TBL] [Abstract][Full Text] [Related]
14. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
McIntosh K; Balch C; Tiwari AK
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems.
Dianat-Moghadam H; Heidarifard M; Jahanban-Esfahlan R; Panahi Y; Hamishehkar H; Pouremamali F; Rahbarghazi R; Nouri M
J Control Release; 2018 Oct; 288():62-83. PubMed ID: 30184466
[TBL] [Abstract][Full Text] [Related]
16. Implication of cancer stem cells in cancer drug development and drug delivery.
Chow EK
J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
[TBL] [Abstract][Full Text] [Related]
17. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.
Mokhtarzadeh A; Hassanpour S; Vahid ZF; Hejazi M; Hashemi M; Ranjbari J; Tabarzad M; Noorolyai S; de la Guardia M
J Control Release; 2017 Nov; 266():166-186. PubMed ID: 28941992
[TBL] [Abstract][Full Text] [Related]
18. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
Kim JK; Jeon HY; Kim H
Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
Hong IS; Lee HY; Nam JS
Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]